These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36481189)

  • 21. NeoSeq: a new method of genomic sequencing for newborn screening.
    Wang H; Yang Y; Zhou L; Wang Y; Long W; Yu B
    Orphanet J Rare Dis; 2021 Nov; 16(1):481. PubMed ID: 34794485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
    J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty Years of Neonatal Screening for Congenital Adrenal Hyperplasia in North-Eastern Italy: Role of Liquid Chromatography-Tandem Mass Spectrometry as a Second-Tier Test.
    Cavarzere P; Camilot M; Palma L; Lauriola S; Gaudino R; Vincenzi M; Antoniazzi F; Teofoli F; Piacentini G
    Horm Res Paediatr; 2022; 95(3):255-263. PubMed ID: 35350013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Need and Challenges in Establishing Newborn Screening Programs for Inherited Metabolic Disorders in Developing Countries.
    Wasim M; Khan HN; Ayesha H; Awan FR
    Adv Biol (Weinh); 2023 Jul; 7(7):e2200318. PubMed ID: 37017505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
    Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
    J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newborn screening by tandem mass spectrometry: ethical and social issues.
    Avard D; Vallance H; Greenberg C; Potter B
    Can J Public Health; 2007; 98(4):284-6. PubMed ID: 17896737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of Classic Homocystinuria in Two Boys Presenting with Acute Cerebral Venous Thrombosis and Neurologic Dysfunction after Normal Newborn Screening.
    Asamoah A; Wei S; Jackson KE; Hersh JH; Levy H
    Int J Neonatal Screen; 2021 Jul; 7(3):. PubMed ID: 34449521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of methylmalonic acid, 2-methylcitric acid, and total homocysteine in dried blood spots by liquid chromatography-tandem mass spectrometry: A reliable follow-up method for propionylcarnitine-related disorders in newborn screening.
    Hu Z; Yang J; Lin Y; Wang J; Hu L; Zhang C; Zhang Y; Huang X
    J Med Screen; 2021 Jun; 28(2):93-99. PubMed ID: 32615850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanded newborn screening and confirmatory follow-up testing for inborn errors of metabolism detected by tandem mass spectrometry.
    Ozben T
    Clin Chem Lab Med; 2013 Jan; 51(1):157-76. PubMed ID: 23183752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI.
    Chan MJ; Liao HC; Gelb MH; Chuang CK; Liu MY; Chen HJ; Kao SM; Lin HY; Huang YH; Kumar AB; Chennamaneni NK; Pendem N; Lin SP; Chiang CC
    J Pediatr; 2019 Feb; 205():176-182. PubMed ID: 30409495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.
    De Jesús VR; Adam BW; Mandel D; Cuthbert CD; Matern D
    Mol Genet Metab; 2014; 113(1-2):67-75. PubMed ID: 25066104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Australian healthcare professionals' perspectives on the ethical and practical issues associated with genomic newborn screening.
    Cao M; Notini L; Ayres S; Vears DF
    J Genet Couns; 2023 Apr; 32(2):376-386. PubMed ID: 36245433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience.
    Gragnaniello V; Burlina AP; Polo G; Giuliani A; Salviati L; Duro G; Cazzorla C; Rubert L; Maines E; Germain DP; Burlina AB
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34199132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LC-MS/MS progress in newborn screening.
    Lehotay DC; Hall P; Lepage J; Eichhorst JC; Etter ML; Greenberg CR
    Clin Biochem; 2011 Jan; 44(1):21-31. PubMed ID: 20709048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lessons learnt from implementing change in newborn bloodspot screening processes over more than a decade: Midwives, genetics and education.
    Nisselle A; Bishop M; Charles T; Morrissy S; King E; Metcalfe S; Gaff C
    Midwifery; 2019 Dec; 79():102542. PubMed ID: 31569029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot study of newborn screening of inborn error of metabolism using tandem mass spectrometry in Malaysia: outcome and challenges.
    Yunus ZM; Rahman SA; Choy YS; Keng WT; Ngu LH
    J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1031-9. PubMed ID: 27544719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second-tier Testing for 21-Hydroxylase Deficiency in the Netherlands: A Newborn Screening Pilot Study.
    Stroek K; Ruiter A; van der Linde A; Ackermans M; Bouva MJ; Engel H; Jakobs B; Kemper EA; van den Akker ELT; van Albada ME; Bocca G; Finken MJJ; Hannema SE; Mieke Houdijk ECA; van der Kamp HJ; van Tellingen V; Paul van Trotsenburg AS; Zwaveling-Soonawala N; Bosch AM; de Jonge R; Heijboer AC; Claahsen-van der Grinten HL; Boelen A
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4487-e4496. PubMed ID: 34171085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newborn screening for lysosomal storage diseases: an ethical and policy analysis.
    Ross LF
    J Inherit Metab Dis; 2012 Jul; 35(4):627-34. PubMed ID: 22189599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry.
    Tortorelli S; Turgeon CT; Lim JS; Baumgart S; Day-Salvatore DL; Abdenur J; Bernstein JA; Lorey F; Lichter-Konecki U; Oglesbee D; Raymond K; Matern D; Schimmenti L; Rinaldo P; Gavrilov DK
    J Pediatr; 2010 Aug; 157(2):271-5. PubMed ID: 20394947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tandem mass spectrometry-based multiplex assays for α-mannosidosis and fucosidosis.
    Kumar AB; Hong X; Yi F; Wood T; Gelb MH
    Mol Genet Metab; 2019 Jul; 127(3):207-211. PubMed ID: 31235216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.